While CA is on medical leave: "leading the Company’s continued priorities of lifting the clinical hold on the use of leronlimab in the HIV population, advancing the development of the NASH phase 2b clinical trial for submission to the FDA, and exploring potential strategic business opportunities." i.e., everybody CA was bugging will now have two new people making contact just to introduce themselves.